Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 12-1999 | |
| Sales | 2,029 | 6,251 | 1,114 | 2,206 | 1,513 |
| Cost of Goods | 670 | 2,394 | 354 | 538 | 486 |
| Gross Profit | 1,359 | 3,857 | 760 | 1,668 | 1,027 |
| Operating Expenses | 3,931 | 13,860 | 4,169 | 3,666 | 5,988 |
| Operating Income | -1,902 | -9,609 | -3,055 | -1,460 | -4,475 |
| Interest Expense | 30 | 351 | 291 | 19 | 164 |
| Other Income | 718 | 1,315 | 372 | 103 | 68 |
| Pre-tax Income | -1,214 | -8,645 | -2,974 | -1,376 | -4,571 |
| Net Income Continuous | -1,214 | -8,645 | -2,974 | -1,376 | -4,571 |
| Net Income | $-1,214 | $-8,645 | $-2,974 | $-1,376 | $-4,571 |
| EPS Basic Total Ops | -0.08 | -1.05 | -0.50 | -0.36 | -1.32 |
| EPS Basic Continuous Ops | -0.08 | -1.05 | -0.50 | -0.36 | -1.32 |
| EPS Diluted Total Ops | -0.08 | -1.05 | -0.50 | -0.36 | -1.32 |
| EPS Diluted Continuous Ops | -0.08 | -1.05 | -0.50 | -0.36 | -1.32 |
| EBITDA(a) | $-1,676 | $-9,168 | $-2,931 | $-1,460 | $-4,240 |